Cardiac output (CO) is monitored routinely in critically ill patients in order to titrate therapy to maintain adequate tissue perfusion. Thermodilution measurement of CO using a pulmonary arterial catheter (PAC) is considered as a gold standard, but the value of the PAC has been questioned in recent years and its impact on outcome is controversial. 1 2 To avoid the risks associated with PAC, alternative techniques 3 have been developed for routine CO monitoring. 4 These techniques include transthoracic bioimpedance, oesophageal Doppler, arterial pulse wave analysis (Vigileo w ), transthoracic echocardiography (TTE), and more recently ECG -Sp O 2 estimated Continuous Cardiac Output system (esCCO).
The esCCO measurement system (Nihon Kohden w , Tokyo, Japan) is a truly non-invasive system. It estimates CO with an ECG and a percutaneous oxygen saturation waveform. 5 The arterial compliance is evaluated with pulse wave transit time (PWTT), pulse pressure (PP) measured by arterial pressure cuffs, and patient characteristics (height, weight, age, and sex).
The validity of esCCO monitoring has not been evaluated for critically ill patients in intensive care. Therefore, we performed an observational blinded study to evaluate the agreement between CO measurement obtained using TTE (CO TTE ) and the esCCO system (CO esCCO ). Non-invasive CO measurement with TTE has been validated in other studies. 6 -10 McLean and colleagues 9 achieved excellent cor-and 7%. 7 Bergenzaun and colleagues 11 have showed that TTE was feasible for 95% of patients admitted to the intensive care unit (ICU). We choose to use TTE as our reference technique for CO measurement, because this was the technique used routinely in our centre for initial flow evaluation. 12 TTE has the advantage of being non-invasive, painless, and immediately feasible in patients with spontaneous or mechanical ventilation. The primary aim of this study was to evaluate the agreement between CO TTE and CO esCCO . On the basis of the work of Critchley and Critchley, 13 we prospectively decided that the new technique (esCCO) would be considered suitable to replace TTE for CO estimation if limits of agreement represented ,30% of the mean CO value. A secondary aim was to evaluate the ability of esCCO measurements to detect CO change, and a concordance rate of 80% was considered the upper limit of acceptance for reliable trending. 14 
Methods
This single-centre observational study was conducted in the ICU of Narbonne Hospital, France. After institutional approval, 38 patients admitted to ICU were included. No additional invasive procedure or blood samples were necessary for this study; therefore, the need for informed consent was waived. 15 Patients from all diagnostic categories were included. Patients were excluded if they were ,18 yr old, or if they had severe aortic stenosis.
Measured variables
Patient characteristics (age, sex, height, and weight), SAPS2, use of vasoactive agents, and haemodynamic data, that is, heart rate (HR), systemic pressure (systolic, diastolic, and mean), and PWTT, were collected. In addition, we measured CO using both esCCO and TTE. A calibration of esCCO system, with standard monitoring, was made before each measurement. The investigators were blinded to the results of each other. This process was repeated each time a patient required a CO reading during a period when an investigator was available. Consequently, a variable number of CO readings were obtained per patient.
esCCO measurements
Initial standard monitoring at the admission included continuous ECG, non-invasive arterial pressure, pulse oximetry, and CO measurement using esCCO monitor (CO esCCO ). The algorithm calculates esCCO stroke volume (SV) continuously with the negative correlation between SV and PWTT. 5 PWTT is the measure of the interval between the ECG R wave and the pulse plethysmograph upstroke. 16 Both the ECG and the plethysmograph wave were obtained from standard monitoring equipment. SV can be expressed according to the equation:
where the constant K quantifies arterial compliance and vascular resistance. PP, corresponding to PWTT, is expressed by the equation:
a is a value obtained experimentally from previous studies. b is determined by the following equation:
Multivariate analysis based on age, sex, height, weight, and arterial pressure and also the patient's HR and PWTT at the initial point of calibration is performed to obtain the CO value used.
TTE measurements
The TTE measurements were taken by an investigator blinded to the measurements determined by esCCO. All TTE measurements were performed using a 'Sonosite w MicroMaxx' with a probe of 2 -4 MHz. The Doppler estimated CO (CO TTE ) was derived from the Doppler estimated SV using the velocity-time integral (VTI) of flow through the left ventricular outflow tract (LVOT), the diameter of the LVOT, and HR recorded during the imaging study, using the following formula:
Aortic VTI was recorded by pulsed-wave Doppler from an apical long-axis view by placing a 5 mm Doppler sample volume in the LVOT at the level of the aortic valve. The VTI value was average over five consecutive measurements. The diameter for LVOT is measured at the aortic annulus from the inner edge to inner edge in a parasternal long-axis view. As the estimate of central venous pressure by the central venous catheter was not always available, a semiquantitative approach was used by the assessment of the inferior vena cava (IVC) diameter and respiratory response: 5 mm Hg if IVP was not dilated and with a caval index of .50%, 10 mm Hg if the IVC was dilated, but with an index of .50%, and 15 mm Hg if the IVC was dilated and with an index of ,50% (,12% during mechanical ventilation). 17 18 Systemic vascular resistance (SVR) was estimated using the equation:
where CO TTE was our best estimate of CO.
Statistical analysis
The normality of the quantitative data was verified using a Kolmogorov -Smirnov test, and expressed as means standard deviation (SD). The sample size (at least 84 measurements) was calculated for an equivalence trial 19 with a range of equivalence of +0. and limits of agreement were in the presence of repeated measurements in each subject, we used the method described by Myles and Cui 20 to take account of repeated measures. The method described by Myles and Cui uses a random effects model to estimate the within-subject variance. For studying the ability of esCCO to follow changes or trends in CO, a four quadrant plot was performed, and the concordance of the direction of change between consecutive readings from the esCCO and TTE was scored as a percentage of data point that agreed. We measured the concordance rate with no data exclusion. The magnitude of CO changes and degree of agreement were represented using a polar plot, in conformity with the methodology described previously by Critchley and colleagues. 14 21 22 The distance from the centre of the plot represents the mean change in CO and the angle with the horizontal axis represents agreement. The more the CO changes are in agreement, the more the data pairs are distributed closely along the horizontal radial axis. Data with good trending will lie within the +308 limits. However, data with poor trending will be scattered throughout the plot and lie outside the limits of good trending ability. Moreover, the limits of agreement proposed by Critchley and colleagues 22 for good trending ability were an angular bias less than +58 and radial limits of agreement of less than +308 when a central zone with radial limits of +0.5 litre min 21 (i.e. dominated by a large random error)
was excluded from the analysis. The effect of HR difference (DHR), PP difference (DPP), MAP difference (DMAP), and PWTT difference (DPWTT) between each measurement point on DCO esCCO and DCO TTE was evaluated by the linear mixed effect model. All results were corrected for repeated measurements. The statistical analysis was performed using R software, 23 SigmaPlot 11 (Systat Software, Inc., San
Jose, CA, USA), and Tanagra 1.4.35 (Rakotomalala, Lyon University, France).
Results
Thirty-eight patients were included in this study (Table 1) . Six patients were excluded from the study: four for a calibration problem in the context of arrhythmia, one because the plethysmograph wave was absent in the context of septic shock with disseminated intravascular coagulation, and one because a good quality of the transthoracic echo-Doppler was impossible in the context of left pneumothorax. A total of 103 pairs of CO TTE and CO esCCO data were analysed. The overall mean CO esCCO was 7 (1.9) litre min 21 , which was significantly higher than the overall mean CO TTE , which was 5.6 (1.4) litre min 21 (P,0.0001).
Bland and Altman analysis
Analysis of the overall relationship between CO TTE and CO esCCO (Fig. 1) showed a significant correlation between CO TTE and CO esCCO (R¼0.61, P,0.0001). The bias and limits of agreement were 21.6 litre min 21 (24.7; +1.5 litre min 21 ) (Fig. 2) . The percentage error for CO measurement was 49%.
Trending ability
The changes in CO between two consecutives measurements, as measured with TTE and esCCO, were also compared. The linear mixed effect model showed a significant correlation between DCO TTE and DCO esCCO (R¼0.63, P,0.0001). Twentyseven per cent of variations in CO yielded opposite changes, that is, negative variation with one technique and positive with the other. These data points are located in the upper left and lower right corners of Figure 3 . The polar plot represents the trending ability and is shown in Figure 4 . Sixty-three per cent of the data points lie within the +308 lines. After exclusion of values with DCO mean ,0.5 litre min 21 , 82% of the data points lie within the +308 lines, with an angular bias (SD) of 298 (238), and radial limits of agreement from 2548 to +368, which was superior to the limits of agreement Comparison of esCCO and echo-Doppler proposed by Critchley and colleagues 22 for good trending ability (i.e. angular bias less than +58 and radial limits of agreement of less than +308). Also, there was a significant correlation between DCO esCCO and DHR, DPP, DMAP, and DPWTT. DCO TTE appeared correlated only with DHR and DPWTT ( Table 2) . The Bland -Altman analysis was corrected for repeated measurements. To exclude the mixing of data, we calculate the mean difference between measurements for each patient; each point represents one patient.
Effect of SVR on the bias
There was a significant log-linear relationship between the bias and the estimation of SVR (R¼20.45, P,0.0001; Fig. 5 ).
Discussion
To our knowledge, this is the first study conducted in critically ill patients to assess the agreement between CO measurements using a new non invasive technique (esCCO), derived from PWTT, with reference values obtained using the TTE. TTE is accepted as a reliable method for CO measurement in clinical practice and has been validated in comparison with thermodilution by several studies. 6 -10 McLean and colleagues 9 reported a TTE bias of 0.2 litre min 21 and limits of agreement of 21.5 to +1.9 litre min 21 . The inter-rater variability was good and varied between 5% 11 and 7%. 7 In our centre, this technique has been routinely used as a noninvasive alternative to thermodilution. Because this technique has the advantage of being fully non-invasive, it can be used in the early phase of sepsis 12 in patients with spontaneous ventilation and those with mechanical ventilation. Thus, we decided to use TTE as our reference method for CO measurement. The CO esCCO percentage error of 49% was above the range considered clinically acceptable. Apart from our study, the esCCO system has never been tested in ICU, but the principle of calculation is analogous to pulse contour-derived CO (Vigileo w ) with the advantage of not requiring arterial catheterization. The percentage error of 49% was similar to that of the other study comparing pulse contour-derived CO (Vigileo w ) with transoesophageal echocardiography, 24 25 thermodilution, 26 27 or TTE. 28 Furthermore, esCCO failed to reliably trend CO data, with a concordance compared with a TTE of 73%, which was below an acceptable level of 80%. 14 The initial calibration of esCCO depends on patient characteristics (age, weight, height, gender) and the measures of PP and PWTT. Its exact algorithm remains undisclosed by the manufacturer, but relies on the assumption that SV is proportional to PP and to a factor reflecting arterial compliance, such as patient characteristics and PWTT. 16 29 However, arterial pressure may change so quickly that intermittent non-invasive measurements may be too slow and inaccurate to allow early detection and prompt treatment. Therefore, PWTT offers beat-to-beat cardiovascular information. The esCCO algorithm assumed a linear relationship between PWTT and arterial pressure. This relationship was directly proportional in healthy volunteers, but was altered in patients with heart failure. 30 Otherwise, a previous study indicated that oscillometric measurements of arterial pressure underestimated direct intra-arterial readings, and although this was observed for all levels of arterial pressure, the negative bias was larger for systolic arterial pressure measurements. 31 There was a log-linear relationship between SVR and an increase in the bias. The estimation of SV by the equation SV¼K×(a×PWTT+b) was a linear approximation. 5 PWTT was divided into three intervals: (i) the Comparison of esCCO and echo-Doppler pre-ejection period, (ii) the PWTT through the elastic artery, and (iii) the PWTT through peripheral arteries. The PWTT through the elastic and peripheral arteries was dependent on the blood vessel resistance. According to the BramwellHill relationship, 32 derived from Newton's second law of motion, the elastic arterial pulse wave velocity is expressed as follows:
where DP/DV is the arterial elasticity, V the baseline volume in steady-state conditions, and r the blood density. Consequently, the esCCO does not provide reliable measurements when changes in arterial compliance and peripheral resistance occur. This problem is similar to another non-invasive technique such as Vigileo w : the study of Biancofiore and colleagues, 26 comparing the CO measured by Vigileo w and thermodilution, showed clearly a significant relationship between bias and SVR. In addition, CO esCCO was affected by changes in PP, signifying that CO esCCO was vulnerable to changes in vascular tone at the initial point of calibration. These facts may concluded that in this population, the agreement of Doppler echocardiography with Fick measurements of CO was closer than that obtained by thermodilution and independent from the presence of low CO, tricuspid regurgitation, or both. Therefore, these data indicated that the Doppler echocardiography method for measuring CO represented a valid alternative to invasive methods. Ideally, the highly reliable reference standard to make comparisons of CO is an aortic flow probe applied directly to the aorta, but this technique is not possible in clinical practice. TTE is a non-invasive method for the estimation of CO by measuring the VTI directly through the LVOT. However, it does not allow continuous monitoring of CO, hence the search for alternative techniques such as esCCO. For assessing trending ability, despite no current consensus, we have used: (i) four quadrant plot of serial change in CO with concordance analysis, which is the method most frequently used with the advantage of showing the relationship between paired measurement and permit to compare results from different study and (ii) the polar plot as described recently by Critchley and colleagues. 14 22 The angular bias was greater than +58, indicating that the calibration of the esCCO system significantly differed from our reference method, and the radial limits of agreements were greater than +308, indicating a poor trending ability. 22 In conclusion, we found a significant correlation between the two methods of measuring CO in ICU patients, but the percentage error of 49% is still clinically unacceptable. The concordance rate of 73% during CO changes is insufficient. Therefore, the esCCO monitor cannot be recommended for critically ill patients. An improved calibration algorithm seems necessary for increasing the accuracy of esCCO in the future.
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